Stock offerings
Cogent Biosciences Announces Pricing of $200 Million Underwritten Public Offering
Cogent Biosciences, a biotechnology company focused on developing precision therapies for genetically defined diseases, has announced the pricing of a $200 million underwritten public offering. The offering, which consists of 22,222,223 shares of common stock, is being sold by Cogent at a public offering price of $9.00